Alphatec Stock (NASDAQ:ATEC)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$8.97

52W Range

$6.82 - $23.29

50D Avg

$8.41

200D Avg

$13.87

Market Cap

$1.39B

Avg Vol (3M)

$3.57M

Beta

0.85

Div Yield

-

ATEC Company Profile


Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal lumbar interbody fusion pedicle-based access system, the Sigma PTP Access and Patient Positioning System, and the Squadron lateral retractor, all designed to optimize surgical outcomes. The company's robust line of spinal fixation devices features the Invictus Spinal Fixation System, capable of addressing various thoracolumbar pathologies, alongside its minimally invasive SingleStep System and adaptable Modular Fixation Systems, which enhance screw modularity. Further fixation options include the OsseoScrew system for spinal column restoration and the comprehensive Arsenal spinal fixation platform, catering to a spectrum of degenerative to deformity procedures. Alphatec also provides anterior lumbar plating solutions like the Aspida Anterior Lumbar Plating System for interbody fusion and the AMP Anti-Migration Plate, in addition to cervical fixation options such as the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Its portfolio extends to interbody implants, including IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Implants. A comprehensive suite of biologics is also available, featuring Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. The company additionally offers EOS imaging products. Alphatec Holdings markets its diverse product range throughout the United States via a network of independent distributors and its own direct sales force. Established in 1990, the company's headquarters are located in Carlsbad, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

913

IPO Date

Jun 12, 2006

Website

ATEC Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Products And Services$764.15M$611.56M$482.26M

Fiscal year ends in Dec 25 | Currency in USD

ATEC Financial Summary


Dec 25Dec 24Dec 23
Revenue-$611.56M$482.26M
Operating Income$-82.13M$-136.17M$-173.40M
Net Income$-143.36M$-162.12M$-186.64M
EBITDA$-82.13M$-53.87M$-110.59M
Basic EPS$-0.96$-1.13$-1.54
Diluted EPS$-0.96$-1.13$-1.54

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 05, 26 | 12:00 AM
Q4 25Feb 24, 26 | 4:30 PM
Q3 25Oct 30, 25 | 4:30 PM

Peer Comparison


TickerCompany
IDYAIDEAYA Biosciences, Inc.
IRONDisc Medicine, Inc.
HTFLHeartflow, Inc. Common Stock
ADPTAdaptive Biotechnologies Corporation
CDTXCidara Therapeutics, Inc.
SGRYSurgery Partners, Inc.
LIVNLivaNova PLC
ZLABZai Lab Limited
LEGNLegend Biotech Corporation
SRRKScholar Rock Holding Corporation